Tradename | Company | Number | Date | Products |
---|---|---|---|---|
INVELTYS | Alcon Research | N-210565 RX | 2018-08-22 | 1 products, RLD, RS |
EYSUVIS | Alcon Research | N-210933 RX | 2020-10-26 | 1 products, RLD, RS |
LOTEMAX | Bausch Health Companies | N-020583 RX | 1998-03-09 | 1 products, RLD, RS |
ALREX | Bausch Health Companies | N-020803 RX | 1998-03-09 | 1 products, RLD, RS |
LOTEMAX | Bausch Health Companies | N-200738 RX | 2011-04-15 | 1 products, RLD, RS |
LOTEMAX | Bausch Health Companies | N-202872 RX | 2012-09-28 | 1 products, RLD, RS |
LOTEMAX SM | Bausch Health Companies | N-208219 RX | 2019-02-22 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ZYLET | Bausch Health Companies | N-050804 RX | 2004-12-14 | 1 products, RLD, RS |
Expiration | Code | ||
---|---|---|---|
LOTEPREDNOL ETABONATE, EYSUVIS, ALCON LABS INC | |||
2023-10-26 | NP |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Loteprednol Etabonate, Lotemax Sm, Bausch And Lomb Inc | |||
10596107 | 2036-12-23 | DP | U-2764 |
11534395 | 2036-01-26 | DP | U-2764 |
Loteprednol Etabonate, Eysuvis, Alcon Labs Inc | |||
9056057 | 2033-05-03 | DP | U-2491 |
9393213 | 2033-05-03 | DP | |
9532955 | 2033-05-03 | U-2491 | |
9737491 | 2033-05-03 | U-2492 | |
9827191 | 2033-05-03 | DP | U-2493, U-2985 |
10058511 | 2033-05-03 | DP | U-2492 |
10646436 | 2033-05-03 | DP | |
10688045 | 2033-05-03 | DP | |
10857096 | 2033-05-03 | U-2985 | |
10940108 | 2033-05-03 | U-2985 | |
10945948 | 2033-05-03 | U-2985 | |
10993908 | 2033-05-03 | U-3117 | |
11219596 | 2033-05-03 | U-2985 | |
11596599 | 2033-05-03 | U-2985 | |
11642317 | 2033-05-03 | DP | |
Loteprednol Etabonate, Inveltys, Alcon Labs Inc | |||
10646437 | 2033-05-03 | DP | |
10864219 | 2033-05-03 | U-3011 | |
11219597 | 2033-05-03 | U-3278, U-3279 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | 1 | — | 11 | 3 | 2 | 17 |
Dry eye syndromes | D015352 | — | H04.12 | 1 | 2 | 3 | 5 | 2 | 13 |
Allergic conjunctivitis | D003233 | EFO_0007141 | H10.44 | 1 | 1 | 1 | 4 | — | 7 |
Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | 2 | 2 | 1 | — | 5 |
Corneal edema | D015715 | EFO_1000879 | H18.20 | — | — | — | 3 | — | 3 |
Conjunctivitis | D003231 | HP_0000509 | H10 | — | — | 1 | 2 | — | 3 |
Intraocular pressure | D007429 | — | — | — | — | — | 2 | — | 2 |
Ocular hypertension | D009798 | EFO_1001069 | H40.0 | — | — | — | 1 | 1 | 2 |
Meibomian gland dysfunction | D000080343 | — | H02.88 | — | — | — | 1 | 1 | 2 |
Pseudophakia | D019591 | — | — | — | — | — | 1 | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pain | D010146 | EFO_0003843 | R52 | — | — | 5 | — | — | 5 |
Cataract | D002386 | HP_0000518 | H26.9 | — | — | 4 | — | — | 4 |
Blepharitis | D001762 | EFO_0009536 | H01.0 | — | 1 | 2 | — | — | 3 |
Keratitis | D007634 | HP_0000491 | H16 | — | — | 2 | — | — | 2 |
Bacterial conjunctivitis | D003234 | EFO_1000829 | H10.0 | — | — | 1 | — | — | 1 |
Keratoconjunctivitis | D007637 | — | H16.2 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypersensitivity | D006967 | HP_0012393 | T78.40 | 1 | — | — | — | — | 1 |
Keratoconus | D007640 | EFO_0004223 | H18.6 | 1 | — | — | — | — | 1 |
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Eye pain | D058447 | HP_0200026 | H57.1 | 1 | — | — | — | — | 1 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | — | — | — | — | 1 | 1 |
Macular edema | D008269 | — | — | — | — | — | — | 1 | 1 |
Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | — | — | — | — | 1 | 1 |
Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | — | — | — | 1 | 1 |
Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | — | — | 1 | 1 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 1 | 1 |
Drug common name | Loteprednol etabonate |
INN | — |
Description | Loteprednol etabonate is an etabonate ester, an 11beta-hydroxy steroid, a steroid ester, an organochlorine compound, a steroid acid ester and a 3-oxo-Delta(1),Delta(4)-steroid. It has a role as an anti-inflammatory drug. It is functionally related to a loteprednol. |
Classification | Small molecule |
Drug class | prednisone and prednisolone derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C |
PDB | — |
CAS-ID | 82034-46-6 |
RxCUI | — |
ChEMBL ID | CHEMBL1200865 |
ChEBI ID | 31784 |
PubChem CID | 444025 |
DrugBank | DB00873 |
UNII ID | — |